What is the next step in management after a transurethral resection of bladder tumor (TURBT) for bladder cancer has been performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: March 3, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

In a patient with bladder cancer who has undergone transurethral resection of bladder tumor (TURBT) and now has PET imaging showing hypermetabolic lymphadenopathy in the retrocrural, retroperitoneal, and right iliac chain regions suggestive of nodal metastasis, what is the recommended next step in management?

What are the complications of radical cystectomy in patients with stage IV bladder cancer?

In clinically node‑positive stage 3A (cT3a N1) bladder cancer, is radical cystectomy with extended pelvic lymph‑node dissection the preferred treatment?

What is the management of sepsis following Transurethral Resection of Bladder Tumor (TURBT)?

What are the indications for Transurethral Resection of the Prostate (TURP) with Transurethral Resection of Bladder Tumor (TURBT)?

What are the cardiac effects of leukemia, including disease‑related and treatment‑related complications?

I have been on antihypertensive medication for 7 years and self‑prescribed a beta‑blocker for anxiety, took an extra dose before an early‑morning flight and experienced acute hypotension with cold sweats, visual dimming and nausea but normal ECG and troponin; how should I manage this episode and adjust my medication regimen?

What is the recommended duration of dexamethasone therapy for acute transverse myelitis?

What urine albumin‑creatinine ratio (UACR) values determine eligibility for a prospective kidney transplant donor?

Can intravenous immunoglobulin (IVIG) cause seizures?

Is zonisamide appropriate as adjunct therapy for Parkinson’s disease with inadequate levodopa control, and what are the recommended dosing and monitoring guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.